000 | 05865cam a2200553Ia 4500 | ||
---|---|---|---|
001 | ocn904792515 | ||
003 | OCoLC | ||
005 | 20190328114810.0 | ||
006 | m o d | ||
007 | cr |n||||||||| | ||
008 | 150313s2015 ne a ob 001 0 eng d | ||
040 |
_aIDEBK _beng _epn _cIDEBK _dN$T _dEBLCP _dOPELS _dBTCTA _dYDXCP _dOCLCQ _dCDX _dOCLCF _dABH _dDEBSZ _dOCLCQ _dFEM _dIDB _dLVT _dOCLCQ _dSAV _dMERUC _dKIJ _dU3W _dD6H _dNAM _dOCLCO _dMERER _dOCLCO _dOCLCQ _dWYU _dOCLCO _dOCLCQ _dOCLCA |
||
019 |
_a968100088 _a969054602 _a1066458973 |
||
020 |
_a1336100990 _q(electronic bk.) |
||
020 |
_a9781336100992 _q(electronic bk.) |
||
020 |
_a9780128016336 _q(electronic bk.) |
||
020 |
_a0128016337 _q(electronic bk.) |
||
020 | _z9780128015056 | ||
020 | _z0128015055 | ||
035 |
_a(OCoLC)904792515 _z(OCoLC)968100088 _z(OCoLC)969054602 _z(OCoLC)1066458973 |
||
050 | 4 | _aRM301.42 | |
060 | 4 | _aQV 37 | |
072 | 7 |
_aMED _x071000 _2bisacsh |
|
082 | 0 | 4 |
_a615.19 _223 |
100 | 1 |
_aRoy, Kunal, _d1971- _eauthor. |
|
245 | 1 | 0 |
_aUnderstanding the basics of QSAR for applications in pharmaceutical sciences and risk assessment / _h[electronic resource] _cKunal Roy, Supratik Kar, Rudra Narayan Das. |
260 |
_aAmsterdam ; _aBoston : _bAcademic Press, an imprint of Elsevier, _c2015 |
||
264 | 4 | _c�2015 | |
300 |
_a1 online resource : _billustrations |
||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
347 |
_atext file _2rda |
||
588 | 0 | _aOnline resource; title from PDF title page (Ebsco, viewed March 18, 2015). | |
504 | _aIncludes bibliographical references and index. | ||
520 | _aUnderstanding the Basics of QSAR for Applications in Pharmaceutical Sciences and Risk Assessment describes the historical evolution of quantitative structure-activity relationship (QSAR) approaches and their fundamental principles. This book includes clear, introductory coverage of the statistical methods applied in QSAR and new QSAR techniques, such as HQSAR and G-QSAR. Containing real-world examples that illustrate important methodologies, this book identifies QSAR as a valuable tool for many different applications, including drug discovery, predictive toxicology and risk assessment. Written in a straightforward and engaging manner, this is the ideal resource for all those looking for general and practical knowledge of QSAR methods. | ||
505 | 0 | _aMachine generated contents note: 1. Background of QSAR and Historical Developments -- 1.1. Introduction -- 1.2. Physicochemical Aspects of Biological Activity of Drugs and Chemicals -- 1.3. Structure -- Activity Relationship -- 1.4. Historical Development of QSARs: a Journey of Knowledge Enrichment -- 1.5. Applications of QSAR -- 1.6. Regulatory Perspectives of QSAR -- 1.7. Overview and Conclusion -- References -- 2. Chemical Information and Descriptors -- 2.1. Introduction -- 2.2. Concept of Descriptors -- 2.3. Type of Descriptors -- 2.4. Descriptors Commonly Used in QSAR Studies -- 2.5. Overview and Conclusion -- References -- 3. Classical QSAR -- 3.1. Introduction -- 3.2. The Free -- Wilson Model -- 3.3. The Fujita -- Ban Model -- 3.4. The LFER Model -- 3.5. Kubinyi's Bilinear Model -- 3.6. The Mixed Approach -- 3.7. Overview and Conclusions -- References -- 4. Topological QSAR -- 4.1. Introduction -- 4.2. Topology: A Method of Chemical Structure Representation -- 4.3. Graphs and Matrices: Platforms for the Topological Paradigm -- 4.4. Topological Indices -- 4.5. Conclusion and Possibilities -- References -- 5.Computational Chemistry -- 5.1. Introduction -- 5.2.Computer Use in Chemistry -- 5.3. Conformational Analysis and Energy Minimization -- 5.4. Molecular Mechanics -- 5.5. Molecular Dynamics -- 5.6. Quantum Mechanics -- 5.7. Overview and Conclusion -- References -- 6. Selected Statistical Methods in QSAR -- 6.1. Introduction -- 6.2. Regression-Based Approaches -- 6.3. Classification-Based QSAR -- 6.4. Machine Learning Techniques -- 6.5. Conclusion -- References -- 7. Validation of QSAR Models -- 7.1. Introduction -- 7.2. Different Validation Methods -- 7.3.A Practical Example of the Calculation of Common Validation Metrics and the AD -- 7.4. QSAR model reporting format -- 7.5. Overview and Conclusion -- References -- 8. Introduction to 3D-QSAR -- 8.1. Introduction -- 8.2.Comparative Molecular Field Analysis -- 8.3.Comparative Molecular Similarity Indices Analysis -- 8.4. Molecular Shape Analysis -- 8.5. Receptor Surface Analysis -- 8.6. Other Approaches -- 8.7. Overview and Conclusions -- References -- 9. Newer QSAR Techniques -- 9.1. Introduction -- 9.2. HQSAR -- 9.3.G-QSAR -- 9.4. Other Approaches -- 9.5. Overview and Conclusions -- References -- 10. Other Related Techniques -- 10.1. Introduction -- 10.2. Pharmacophore -- 10.3. Structure-Based Design -- Docking -- 10.4.Combination of Structure- and Ligand-Based Design Tools -- 10.5. In sillco Screening of Chemical Libraries: VS -- 10.6. Overview and Conclusions -- References -- 11. SAR and QSAR in Drug Discovery and Chemical Design -- Some Examples -- 11.1. Introduction -- 11.2. Successful Applications of QSAR and Other In Sillco Methods: Representative Examples -- 11.3. Conclusion -- References -- 12. Future Avenues -- 12.1. Introduction -- 12.2. Application Areas -- 12.3. Conclusion -- References. | |
650 | 0 | _aQSAR (Biochemistry) | |
650 | 0 | _aPharmacology. | |
650 | 7 |
_aMEDICAL _xPharmacology. _2bisacsh |
|
650 | 7 |
_aPharmacology. _2fast _0(OCoLC)fst01060259 |
|
650 | 7 |
_aQSAR (Biochemistry) _2fast _0(OCoLC)fst01084801 |
|
650 | 2 |
_aPharmacological Phenomena. _0(DNLM)D000069437 |
|
655 | 4 | _aElectronic books. | |
655 | 0 | _aElectronic book. | |
700 | 1 |
_aKar, Supratik, _eauthor. |
|
700 | 1 |
_aDas, Rudra Narayan, _eauthor. |
|
856 | 4 | 0 |
_3ScienceDirect _uhttp://www.sciencedirect.com/science/book/9780128015056 |
999 |
_c247056 _d247056 |